• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-195 通过调控 CD40 维持非酒精性脂肪性肝病大鼠 Th17/Treg 平衡。

MiR-195 regulates CD40 to maintain Th17/Treg balance in rats with non-alcoholic fatty liver disease.

机构信息

Departments of Liver Diseases, Taizhou People's Hospital, Taizhou 225300, Jiangsu Province, China.

Articular Surgery, Taizhou People's Hospital, Taizhou 225300, Jiangsu Province, China.

出版信息

Biomed Pharmacother. 2020 Apr;124:109930. doi: 10.1016/j.biopha.2020.109930. Epub 2020 Jan 25.

DOI:10.1016/j.biopha.2020.109930
PMID:31991386
Abstract

PURPOSE

This study aims to explore the relationship between miR-195 and CD40 and its effect on Th17/Treg balance in rats with non-alcoholic fatty liver disease (NAFLD).

METHODS

We established rat models of NAFLD and made seven groups, Normal group (without modeling), Model group (model rats), NC group (model rats injected with negative control vector), miR-195 OE group (model rats injected with miR-195 mimic), anti-miR-195 group (model rats injected with miR-195 inhibitor), Si-CD40 group (model rats injected with CD40 silencing vector), and anti-miR-195+Si-CD40 group (model rats injected with miR-195 inhibitor and CD40 silencing vector). Dual-luciferase reporter gene assay verified the targeting relationship between miR-195 and CD40. The mRNA and protein expression levels of miR-195, CD40 as well as Th17/Treg associated cytokines in the liver tissues were detected. The pathological changes of liver tissues were detected, and the liver lesion scoring was carried out. The liver coefficient was calculated. The levels of liver function related indices, and Th17/Treg associated cytokines and inflammatory factors in serum were determined. The proportions of Th17/Treg cells in serum were determined by flow cytometry.

RESULTS

Compared with Normal group, miR-195 expression level in liver tissues of rats in other six groups was significantly reduced (all P < 0.05); the serum levels of AST, ALT, GGT, IL-17, TNF-α, IL-23, IL-6, IL-8, TC, TG, HDL, and LDL, and the Th17/Treg ratio, as well as the mRNA and protein expression levels of CD40, RORyt, IL-17, TNF-α, IL-23, and IL-8 in liver tissues were significantly increased (all P < 0.05); while the mRNA and protein expression levels of Foxp3, and IL-10 level were significantly reduced (all P < 0.05). Compared with Model group, the above parameters showed an opposite trend in miR-195 OE group and Si-CD40 group were significantly reduced (all P < 0.05). Moreover, anti-miR-195 group could aggravate the imbalance of Th17/Treg cells in rats with NAFLD and promote inflammatory response. Compared with anti-miR-195 group, the combined treatment in anti-miR-195+Si-CD40 group can partially avoid the imbalance of Th17/Treg cells, and inhibit inflammatory response.

CONCLUSION

Overexpression of miR-195 can reduce the Th17/Treg ratio to maintain Th17/Treg balance by inhibiting CD40 expression in rats with NAFLD.

摘要

目的

本研究旨在探讨 miR-195 与 CD40 之间的关系及其对非酒精性脂肪性肝病(NAFLD)大鼠 Th17/Treg 平衡的影响。

方法

我们建立了 NAFLD 大鼠模型,并分为七组:正常组(未建模)、模型组(造模组)、NC 组(转染阴性对照载体的模型组)、miR-195 OE 组(转染 miR-195 模拟物的模型组)、抗 miR-195 组(转染 miR-195 抑制剂的模型组)、Si-CD40 组(转染 CD40 沉默载体的模型组)和抗 miR-195+Si-CD40 组(转染 miR-195 抑制剂和 CD40 沉默载体的模型组)。双荧光素酶报告基因实验验证了 miR-195 与 CD40 之间的靶向关系。检测肝组织中 miR-195、CD40 及 Th17/Treg 相关细胞因子的 mRNA 和蛋白表达水平。检测肝组织的病理变化,进行肝损伤评分。计算肝系数。检测血清中肝功能相关指标及 Th17/Treg 相关细胞因子和炎症因子水平。流式细胞术检测血清中 Th17/Treg 细胞的比例。

结果

与正常组相比,其余六组大鼠肝组织中 miR-195 表达水平明显降低(均 P < 0.05);血清中 AST、ALT、GGT、IL-17、TNF-α、IL-23、IL-6、IL-8、TC、TG、HDL 和 LDL 水平以及 Th17/Treg 比值,以及肝组织中 CD40、RORyt、IL-17、TNF-α、IL-23 和 IL-8 的 mRNA 和蛋白表达水平均明显升高(均 P < 0.05);而 Foxp3 和 IL-10 水平的 mRNA 和蛋白表达水平明显降低(均 P < 0.05)。与模型组相比,miR-195 OE 组和 Si-CD40 组上述参数明显降低(均 P < 0.05)。此外,抗 miR-195 组可加重 NAFLD 大鼠 Th17/Treg 细胞失衡,并促进炎症反应。与抗 miR-195 组相比,抗 miR-195+Si-CD40 组联合治疗可部分避免 Th17/Treg 细胞失衡,抑制炎症反应。

结论

过表达 miR-195 可通过抑制 CD40 的表达降低 NAFLD 大鼠 Th17/Treg 比值,维持 Th17/Treg 平衡。

相似文献

1
MiR-195 regulates CD40 to maintain Th17/Treg balance in rats with non-alcoholic fatty liver disease.miR-195 通过调控 CD40 维持非酒精性脂肪性肝病大鼠 Th17/Treg 平衡。
Biomed Pharmacother. 2020 Apr;124:109930. doi: 10.1016/j.biopha.2020.109930. Epub 2020 Jan 25.
2
Inflammatory Cytokines, Adipocytokines, and Th17/Treg Balance in Patients with Nonalcoholic Fatty Liver Disease following Administration of Dahuang Zhechong Pills.大黄蛰虫丸治疗非酒精性脂肪性肝病患者的炎症细胞因子、脂肪细胞因子及 Th17/Treg 平衡。
Genet Res (Camb). 2022 Jan 7;2022:8560831. doi: 10.1155/2022/8560831. eCollection 2022.
3
The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice.Th17/Treg细胞失衡参与小鼠非酒精性脂肪性肝病的进展。
BMC Immunol. 2017 Jun 24;18(1):33. doi: 10.1186/s12865-017-0215-y.
4
MiR-200a expression in CD4+ T cells correlates with the expression of Th17/Treg cells and relevant cytokines in psoriasis vulgaris: A case control study.miR-200a 在 CD4+T 细胞中的表达与寻常型银屑病中 Th17/Treg 细胞及相关细胞因子的表达相关:一项病例对照研究。
Biomed Pharmacother. 2017 Sep;93:1158-1164. doi: 10.1016/j.biopha.2017.06.055.
5
MiR-206 regulates the Th17/Treg ratio during osteoarthritis.miR-206 调控骨关节炎中的 Th17/Treg 比值。
Mol Med. 2021 Jun 19;27(1):64. doi: 10.1186/s10020-021-00315-1.
6
Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response.抑制微小RNA-155通过调节Th17/Treg免疫反应改善实验性自身免疫性心肌炎。
J Mol Med (Berl). 2016 Sep;94(9):1063-79. doi: 10.1007/s00109-016-1414-3. Epub 2016 Apr 6.
7
The Changes of Th17/Treg and Related Cytokines: IL-17, IL-23, IL-10, and TGF-β in Respiratory Syncytial Virus Bronchiolitis Rat Model.呼吸道合胞病毒细支气管炎大鼠模型中Th17/Treg及相关细胞因子:白细胞介素-17、白细胞介素-23、白细胞介素-10和转化生长因子-β的变化
Iran J Allergy Asthma Immunol. 2017 Oct;16(5):386-395.
8
Oleanolic acid regulates the Treg/Th17 imbalance in gastric cancer by targeting IL-6 with miR-98-5p.齐墩果酸通过靶向 miR-98-5p 调控 IL-6 改善胃癌中 Treg/Th17 失衡。
Cytokine. 2021 Dec;148:155656. doi: 10.1016/j.cyto.2021.155656. Epub 2021 Aug 11.
9
Moxibustion regulates T-regulatory/T-helper 17 cell balance by modulating the microRNA-221/suppressor of cytokine signaling 3 axis in a mouse model of rheumatoid arthritis.艾灸通过调节 miRNA-221/细胞因子信号转导抑制因子 3 轴调节类风湿关节炎小鼠模型中的 T 调节/T 辅助 17 细胞平衡。
J Integr Med. 2022 Sep;20(5):453-462. doi: 10.1016/j.joim.2022.06.002. Epub 2022 Jun 10.
10
Chronic intermittent hypoxia promotes the development of experimental non-alcoholic steatohepatitis by modulating Treg/Th17 differentiation.慢性间歇性低氧通过调节 Treg/Th17 分化促进实验性非酒精性脂肪性肝炎的发生。
Acta Biochim Biophys Sin (Shanghai). 2018 Dec 1;50(12):1200-1210. doi: 10.1093/abbs/gmy131.

引用本文的文献

1
Decoding the role of immune T cells: A new territory for improvement of metabolic-associated fatty liver disease.解读免疫T细胞的作用:改善代谢相关脂肪性肝病的新领域。
Imeta. 2023 Jan 18;2(1):e76. doi: 10.1002/imt2.76. eCollection 2023 Feb.
2
Uncovering the Role of Anmeidan against Atherosclerosis from Integrated Network Pharmacology and Pharmacological Experiments.基于网络药理学和药理实验揭示阿美丹抗动脉粥样硬化的作用
Comb Chem High Throughput Screen. 2025;28(6):915-930. doi: 10.2174/0113862073281925240417062009.
3
MicroRNAs and Nonalcoholic Steatohepatitis: A Review.
微小 RNA 与非酒精性脂肪性肝炎:综述。
Int J Mol Sci. 2023 Sep 23;24(19):14482. doi: 10.3390/ijms241914482.
4
IL-23/IL-17 Axis in Chronic Hepatitis C and Non-Alcoholic Steatohepatitis-New Insight into Immunohepatotoxicity of Different Chronic Liver Diseases.慢性丙型肝炎和非酒精性脂肪性肝炎中的白细胞介素-23/白细胞介素-17轴——对不同慢性肝病免疫性肝毒性的新认识
Int J Mol Sci. 2023 Aug 5;24(15):12483. doi: 10.3390/ijms241512483.
5
CircLDLR acts as a sponge for miR-667-5p to regulate SIRT1 expression in non-alcoholic fatty liver disease.环状 LDLR 通过海绵吸附 miR-667-5p 调控非酒精性脂肪肝病中 SIRT1 的表达。
Lipids Health Dis. 2022 Nov 29;21(1):127. doi: 10.1186/s12944-022-01740-9.
6
Regulatory T cells and their associated factors in hepatocellular carcinoma development and therapy.调节性 T 细胞及其相关因素在肝细胞癌发生和治疗中的作用。
World J Gastroenterol. 2022 Jul 21;28(27):3346-3358. doi: 10.3748/wjg.v28.i27.3346.
7
Long non-coding RNA growth arrest specific 5 regulates the T helper 17/regulatory T balance by targeting miR-23a in myasthenia gravis.长非编码 RNA 生长停滞特异性 5 通过靶向 miR-23a 调节重症肌无力中的辅助性 T 细胞 17/调节性 T 细胞平衡。
J Int Med Res. 2022 Jun;50(6):3000605211053703. doi: 10.1177/03000605211053703.
8
Diet and Gut Microbiota Interaction-Derived Metabolites and Intrahepatic Immune Response in NAFLD Development and Treatment.饮食与肠道微生物群相互作用衍生的代谢产物以及非酒精性脂肪性肝病发生发展和治疗中的肝内免疫反应
Biomedicines. 2021 Dec 13;9(12):1893. doi: 10.3390/biomedicines9121893.
9
Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion.针对非酒精性脂肪性肝病及非酒精性脂肪性肝病相关肝细胞癌治疗的T细胞亚群:一种观点。
Front Med (Lausanne). 2021 Nov 18;8:789859. doi: 10.3389/fmed.2021.789859. eCollection 2021.
10
Circ_0057558 promotes nonalcoholic fatty liver disease by regulating ROCK1/AMPK signaling through targeting miR-206.环状 RNA 0057558 通过靶向 miR-206 调控 ROCK1/AMPK 信号通路促进非酒精性脂肪性肝病。
Cell Death Dis. 2021 Aug 26;12(9):809. doi: 10.1038/s41419-021-04090-z.